alexa Lyme disease | Australia | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Read more

Recommended Journals

Relevant Topics

Lyme Disease

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Lyme disease

    Lyme disease is caused by a bacterium transmitted to humans via a tick bite. The CDC (Center for Disease Control) claims that Lyme Borreliosis is the most common and fastest growing infectious illness in the United States. The disease can cause a variety of flu-like symptoms such as fever, achy joints, fatigue and headache.

  • Lyme disease

    From 1988 to 1994 at Westmead Hospital, 78 (1.8%) of 4,372 from local patients with suspected LD were positive for IgG by ELISA and IFAT. All 78 were tested by WB, using North American and European strains of Borrelia; 46 sera showed one or more bands. None, including those with putative late stage disease, showed more than 4 specific bands and thus were all negative by international criteria. Twenty-four patients with various bacterial, viral or autoimmune syndromes unrelated to LD were tested in parallel and 11/24 showed one or 2 indicative bands. Thus a high degree of cross reactivity was demonstrated with non-LD patients.

  • Lyme disease

    The antibiotic therapy of early LD generally results in complete recovery. A 2 week course of oral doxycycline or amoxycillin for Stage I and a third generation cephalosporin for Stage II are the most commonly used regimens. Treatment of late stage LD is less successful and a chronic or relapsing course is common. A third generation cephalosporin for 3 weeks is recommended.

  • Lyme disease

    currently enrolling patients into a study on neuroborreliosis: comparison of IV Ceftriaxone for three weeks vs. oral Doximycin for four weeks. Hopefully this study (with control CSF specimens) and long follow-ups of patients also will give us new knowledge on markers of how to identify patients with reactive symptomatology triggered by Lyme neuroborreliosis.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings